Search clinical trials for: Semaglutide placebo
Total 53687 results
-
Novo Nordisk A/SActive, not recruitingEarly Alzheimer's DiseaseCanada, United States, Spain, Netherlands, United Kingdom, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, Poland, Denmark, Czechia, Ireland, Norway, Japan, Romania, South Africa, Sweden, ... and more
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, India, Japan, Russian Federation, United Kingdom, Canada, Spain, South Africa, Germany, Greece, United Arab Emirates, Argentina, Puerto Rico
-
Novo Nordisk A/SCompletedObesityUnited States, Israel, United Kingdom, Denmark, Germany, Netherlands, Canada, Argentina, Czechia, Hungary, Poland, Spain, Australia
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | OverweightKorea, Republic of, Hong Kong, Brazil, China
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States
-
Woman'sNovo Nordisk A/SRecruitingPre Diabetes | Postpartum DisorderUnited States
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Italy, Spain, Canada, Hungary
-
Novo Nordisk A/SCompletedObesity | OverweightJapan, Korea, Republic of
-
Novo Nordisk A/SCompletedOverweight or Obesity | Metabolism and Nutrition DisorderUnited States, India, Mexico, Russian Federation, United Kingdom, Canada, Denmark, Finland, Belgium, Japan, Taiwan, France, Poland, Germany, Bulgaria, Argentina, Puerto Rico
-
Novo Nordisk A/SRecruiting
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | Overweight | Healthy VolunteersNetherlands
-
Novo Nordisk A/SCompletedOverweight and ObesityJapan, Korea, Republic of
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
Novo Nordisk A/SCompletedHealthy Volunteers Type 2 DiabetesJapan
-
Novo Nordisk A/SCompletedObesitySpain, United States, France, Russian Federation, Canada, Colombia, South Africa, Norway, Denmark, Saudi Arabia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States
-
University of Texas Southwestern Medical CenterUniversity of North Carolina, Chapel HillRecruiting
-
University Health Network, TorontoRecruitingMajor Depressive DisorderCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Hungary, Greece
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, Austria, Japan, Norway, Puerto Rico
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, Croatia, Russian Federation, United Kingdom, Belgium, Mexico, Austria, Ireland
-
University Medical Center GroningenNovo Nordisk A/SEnrolling by invitationObesity | AlbuminuriaNetherlands, Germany, Spain, Canada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Novo Nordisk A/SCompletedNon-alcoholic SteatohepatitisUnited Kingdom, Spain, United States, France, Germany
-
Novo Nordisk A/SCompletedObesityKorea, Republic of, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Taiwan, Serbia, Algeria, Hungary, China, Ukraine
-
University Medical Centre LjubljanaCompletedPCOS | Gastric Emptying | Semaglutide | Taste, Altered | Tongue Tissue Transcriptome | Central Neural ResponseSlovenia
-
Novo Nordisk A/SCompletedHealthy | DiabetesUnited Kingdom
-
San Francisco Veterans Affairs Medical CenterSuspendedObesity | Overweight | Atrial FibrillationUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Italy, Mexico, United Kingdom, Canada, Denmark, Spain, Netherlands, Malaysia, Taiwan, Germany, Poland, Turkey, Argentina, South Africa, Romania, Thailand, Algeria, Brazil
-
Novo Nordisk A/SCompletedObesity | OverweightGermany
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Israel, Poland, Russian Federation, United Kingdom, Denmark, Finland, Sweden
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedA Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2 | DiabetesGermany
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Loma Linda UniversityNovo Nordisk A/SRecruitingObesity | Weight Loss | Overweight or Obesity | Weight, Body | Obesity; Drug | Weight Loss TrajectoryUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersChina
-
Universitaire Ziekenhuizen KU LeuvenJessa Hospital; Universitair Ziekenhuis Brussel; University Hospital, Antwerp; AZ... and other collaboratorsRecruitingGlucose Intolerance After a Recent History of Gestational DiabetesBelgium
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Sweden, Austria, Denmark
-
Odense University HospitalNot yet recruitingType 2 Diabetes | OsteopeniaDenmark
-
Novo Nordisk A/SCompletedObesityUnited Kingdom, Canada, Denmark, Finland, Spain
-
University College, LondonActive, not recruitingObesity | Diabetes | Metabolic SyndromeUnited Kingdom